Estonja -
Estonjan -
Ravimiamet
thiamin hcl (vit b1) süstelahus
lvovdialek - tiamiin - süstelahus - 50mg 1ml 1ml 10tk
Estonja -
Estonjan -
Ravimiamet
thiamin hcl (vit b1) süstelahus
moshimpharmpreparaty - tiamiin - süstelahus - 50mg 1ml 1ml 10tk
Estonja -
Estonjan -
Ravimiamet
thiamin hcl süstelahus
tov kharkivske farmatsevtychne pidpryemstvo zdorovya narodu - tiamiin - süstelahus - 50mg 1ml 1ml 10tk
Estonja -
Estonjan -
Ravimiamet
thiamin hcl (vit. b1) süstelahus
dalhimfarm oao - tiamiin - süstelahus - 50mg 1ml 1ml 10tk
Estonja -
Estonjan -
Ravimiamet
thiamin hcl süstelahus
ao biopharm - tiamiin - süstelahus - 50mg 1ml 1ml 10tk
Estonja -
Estonjan -
Ravimiamet
neiratax süstelahus
kalceks as - tiamiin+püridoksiin+tsüanokobalamiin+lidokaiin - süstelahus - 50mg+50mg+0,5mg+10mg 1ml 2ml 10tk; 50mg+50mg+0,5mg+10mg 1ml 2ml 5tk
Estonja -
Estonjan -
Ravimiamet
neuromultivit õhukese polümeerikattega tablett
g.l. pharma gmbh - tiamiin+püridoksiin+tsüanokobalamiin - õhukese polümeerikattega tablett - 100mg+200mg+0,2mg 20tk; 100mg+200mg+0,2mg 100tk
Unjoni Ewropea -
Estonjan -
EMA (European Medicines Agency)
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - mitu müeloomit - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
Estonja -
Estonjan -
Ravimiamet
milgamma na injekt süstelahus
woerwag pharma gmbh & co. kg - tiamiin+püridoksiin - süstelahus - 100mg+50mg 1ml 20tk; 100mg+50mg 1ml 5tk; 100mg+50mg 1ml 100tk
Estonja -
Estonjan -
Ravimiamet
milgamma n süstelahus
woerwag pharma gmbh & co. kg - tiamiin+püridoksiin+tsüanokobalamiin+lidokaiin - süstelahus - 50mg+50mg+0,5mg+10mg 1ml 2ml 25tk; 50mg+50mg+0,5mg+10mg 1ml 2ml 5tk